|
Validation and Extension of the PREMM Model for Inherited Colorectal Cancer
|
4R01CA132829-08
|
$449,215
|
$112,304
|
SYNGAL, SAPNA
|
DANA-FARBER CANCER INST
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-11S6
|
$12,771
|
$1,022
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-12S1
|
$113,625
|
$9,090
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-12S2
|
$246,024
|
$19,682
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-12S3
|
$123,494
|
$9,880
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-12S4
|
$163,814
|
$13,105
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
5P30CA118100-12
|
$2,246,011
|
$179,681
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S1
|
$198,450
|
$1,985
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S2
|
$499,325
|
$4,993
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
4P30CA046592-28
|
$6,209,909
|
$62,099
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
UIC Center for Population Health and Health Disparities
|
3P50CA106743-10S2
|
$500,000
|
$55,000
|
WARNECKE, RICHARD
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Translational Approaches to Melanoma Prevention in Children at High Genetic Risk
|
5K07CA196985-02
|
$136,363
|
$45,000
|
WU, YELENA
|
UNIVERSITY OF UTAH
|
|
Towards Understanding Prostate Cancer Heterogeneity
|
4R01CA125612-08
|
$373,464
|
$373,464
|
RUBIN, MARK
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
The Genetic Basis of Neuroblastoma Tumorigenesis
|
4R01CA124709-09
|
$614,290
|
$614,290
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
The Challenge of Individualizing Treatments for Patients with Breast Cancer
|
4P01CA163233-05
|
$2,206,197
|
$242,682
|
KATZ, STEVEN
|
UNIVERSITY OF MICHIGAN
|
|
Statistical Methods for Genetic Epidemiology
|
4R01CA094069-14
|
$562,685
|
$562,685
|
WHITTEMORE, ALICE
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
2P30CA124435-09
|
$3,345,301
|
$33,453
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
SPORE: Brain Tumore SPORE Grant
|
4P50CA097257-14
|
$2,006,093
|
$401,219
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Shared Genomic Segment Analysis and Tumor Subtyping in High-Risk BrCa Pedigrees
|
4R01CA163353-05
|
$570,500
|
$570,500
|
CAMP, NICOLA
|
UNIVERSITY OF UTAH
|
|
San Antonio Center for Biomarkers of Risk for Prostate Cancer (SABOR)
|
2U01CA086402-16
|
$100,000
|
$50,000
|
THOMPSON, IAN
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
RPCI-UPCI Ovarian Cancer SPORE
|
3P50CA159981-04S1
|
$66,758
|
$7,343
|
ODUNSI, KUNLE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
RPCI-UPCI Ovarian Cancer SPORE
|
3P50CA159981-04S2
|
$550,298
|
$60,533
|
ODUNSI, KUNLE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
RPCI-UPCI Ovarian Cancer SPORE
|
4P50CA159981-04
|
$411,793
|
$45,297
|
ODUNSI, KUNLE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
3P30CA016056-39S1
|
$131,625
|
$1,316
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
3P30CA016056-39S2
|
$118,659
|
$1,187
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
3P30CA016056-39S3
|
$99,902
|
$999
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
3P30CA016056-39S4
|
$199,940
|
$1,999
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
3P30CA016056-39S5
|
$447,972
|
$4,480
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
3P30CA016056-39S6
|
$31,320
|
$313
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
3P30CA016056-39S7
|
$749,842
|
$7,498
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Cancer Center Support Grant
|
5P30CA016056-39
|
$4,021,233
|
$40,212
|
JOHNSON, CANDACE
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Role of pharmacogenetics on exemestane metabolism and toxicity
|
4R01CA164366-05
|
$465,866
|
$465,866
|
LAZARUS, PHILIP
|
WASHINGTON STATE UNIVERSITY
|
|
Risk and penetrance of mutations from breast cancer testing panels.
|
5R01CA192393-03
|
$1,299,901
|
$1,299,901
|
COUCH, FERGUS
|
MAYO CLINIC ROCHESTER
|
|
Returning genetic research panel results for breast cancer susceptibility
|
5R01CA190871-03
|
$34,286
|
$17,143
|
BRADBURY, ANGELA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Regional Oncology Research Center
|
3P30CA006973-53S1
|
$60,000
|
$600
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-53S2
|
$114,211
|
$1,142
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-53S3
|
$125,000
|
$1,250
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
4P30CA006973-53
|
$6,995,267
|
$69,953
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Reducing Cervical Cancer in Appalachia
|
3P50CA105632-10S1
|
$499,676
|
$29,981
|
PASKETT, ELECTRA
|
OHIO STATE UNIVERSITY
|
|
Recombination and Regulation
|
ZIA BC 010380
|
$308,071
|
$308,071
|
Strathern, Jeffrey
|
CCR (NCI)
|
|
Rare Cancer Genetics Registry
|
4R01CA160233-05
|
$497,727
|
$497,727
|
FINKELSTEIN, DIANNE
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Ponce School of Medicine-Moffitt Cancer Center partnership (2/2)
|
3U54CA163068-05S1
|
$187,377
|
$13,116
|
MUNOZ-ANTONIA, TERESITA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Ponce School of Medicine-Moffitt Cancer Center partnership (2/2)
|
4U54CA163068-05
|
$1,413,248
|
$98,927
|
MUNOZ-ANTONIA, TERESITA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Ponce School of Medicine-Moffitt Cancer Center Partnership (1/2)
|
3U54CA163071-05S1
|
$185,167
|
$12,962
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
Ponce School of Medicine-Moffitt Cancer Center Partnership (1/2)
|
4U54CA163071-05
|
$1,325,855
|
$92,810
|
MATTA, JAIME
|
PONCE SCHOOL OF MEDICINE
|
|
Pharmacogenomics of Ara-C in AML
|
5R01CA132946-09
|
$310,509
|
$310,509
|
LAMBA, JATINDER
|
UNIVERSITY OF FLORIDA
|
|
Personalized melanoma chemoprevention
|
4R01CA166710-05
|
$318,586
|
$318,586
|
GROSSMAN, DOUGLAS
|
UNIVERSITY OF UTAH
|
|
Personalized Genomic Testing for Melanoma: Maximizing Personal Utility and Reach
|
5R01CA181241-03
|
$657,031
|
$657,031
|
HAY, JENNIFER
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Novel Markers for Disease Outcome in Breast Cancer
|
ZIA BC 010887
|
$488,242
|
$97,648
|
Ambs, Stefan
|
CCR (NCI)
|
|
NK cells, their receptors, transplantation and cancer therapy
|
2P01CA111412-11A1
|
$1,960,158
|
$588,047
|
MILLER, JEFFREY
|
UNIVERSITY OF MINNESOTA
|
Total relevant funding to Genetic Testing for this search: $31,969,055
|